2023 USP Series: Getting Ready: GAP Analysis and Selecting Your Designated Person - On Demand

Recorded On: 07/11/2023

Starting any project can seem like a daunting task. Preparing for the new 2023 version of USP <797> and USP <800> is not small feat. This program will highlight how to perform a sterile compounding gap analysis to start your journey. One major change to the 2023 version is the requirement for a designated person (DP). This session will also highlight who the best individual or individuals may be and how best to ensure their own competency and prepare to manage and handle all aspects of the organization or facilities sterile compounding activities.

Learning Objectives:

  1. Review the basic elements of performing a GAP analysis in relation to sterile compounding activities.
  2. Identify gaps in current policy and practice and learn how to develop an action plan to ensure compliance by November 1, 2023.
  3. Understand how to create a job description for the designated person (DP) and who best on your team can fill that role.
  4. Differentiate the need for site and corporate level policies for multi-stie organizations.

Barbara Petroff, MS, RPh, FASHP, BCSCP, FNHIA, CAC, CSPP, IgCP

Principal

Shawler Petroff LLC

Barbara J. Petroff, MS, RPh, FASHP FNHIA, is currently Principal at Shawler Petroff LLC. In addition she is an accreditation surveyor for the Accreditation Commission for Health Care.  She received her BS in pharmacy at Ohio State University and an MS in administration at Central Michigan University. She has worked in several pharmacy arenas including research, hospital, retail and home infusion. Petroff has served ASHP in many capacities. She also serves as Chair of the Sterile Compounding Practice Committee for the National Home Infusion Association. She was awarded certification in sterile compounding (BCSCP) from the Board of Pharmaceutical Specialties.

No Disclosures to Report

Daniel Kyes, CPhT

Regional Pharmacy Training & Quality Specialist

New England Life Care

Dan Kyes, CPhT, Regional Pharmacy Training and Quality Specialist for New England Life Care in Portland, ME.  Focus on USP 797/800, The Joint Commission Accreditation, training, continuous quality improvement.  Within my organization I help to create and implement SOPs, and improve workflow using flowcharts. Nationally Certified/Licensed as a pharmacy technician in multiple states.  Member of NHIA Sterile Compounding Practice Committee and Faculty with the Sterile Compounding Clinic.  When I am not in the pharmacy you can find me enjoying the beautiful outdoors with my camper, searching for vintage vinyls or traveling with friends and family.

No Disclosures to Report

Key:

Complete
Failed
Available
Locked
2023 USP Series: Getting Ready: GAP Analysis and Selecting Your Designated Person
Recorded 07/11/2023  |  60 minutes
Recorded 07/11/2023  |  60 minutes
You must register to access.
Post Education Quiz
10 Questions  |  2 attempts  |  70/100 points to pass
10 Questions  |  2 attempts  |  70/100 points to pass
You must register to access.
Post Education Survey
5 Questions
5 Questions Getting Ready: GAP Analysis and Selecting Your Designated Person Educational Webinar, Effective 7/11/2023 - 7/11/2026, 1.0 CE 0761-9999-23-465-L07-P&T & 05-115-23-361 RN/RD
You must register to access.
Required to Claim CE
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** _______________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
You must register to access.